Dishman Carbogen Amcis Limited

₹162.18As of Sun 8 Nov 2026, 12:00 UTC
NSE:DCALHealthcare
Country India
PE (Fwd) •••
TSR 9Y CAGR (7.73%)
Div yield —
ROE 1.56%
Biotechnology
Beta (5Y) 0.72
PE TTM 157.2
TSR TTM (44.42%)
Mkt cap ₹25.43B
ROIC 1.57%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹169
3.98%
(28.81%)
Hold 0|2|10|5|5
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
1.46
1.58
1.72
1.90
5.31%
13.14%
28.32%
29.94%
Revenue₹B
3.363
3.319
3.316
3.315
16.72%
9.76%
7.40%
2.83%
Peers (US$261.4M)
Cap (US$)
PE
117.9M
19.70x
Capital
TTM
5Y
10Y
Leveragex
7.305
0.161
0.123
EBIT/Intx
0.189
0.123
0.145
Own earn%
(335.15)
(35.14)
(49.36)
Sh yield%
30.24
37.50
38.84
Owners
Insiders/Inst%
3.85
44.33
Short interest%
2.81
SBC / revenue%
1.01
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
29–32
$1 testx
0.0
Incr. ROIC%
14